Header Logo

Connection

DAWID SCHELLINGERHOUT to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications DAWID SCHELLINGERHOUT has written about Radiopharmaceuticals.
DAWID SCHELLINGERHOUT
Connection Strength
0.279
Radiopharmaceuticals
  1. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res. 2015 Nov 15; 75(22):4708-17.
    View in: PubMed
    Score: 0.085
  2. Molecular neuroimaging: the basics. Semin Roentgenol. 2014 Apr; 49(2):225-33.
    View in: PubMed
    Score: 0.075
  3. Molecular imaging of novel cell- and viral-based therapies. Neuroimaging Clin N Am. 2006 Nov; 16(4):655-79, ix.
    View in: PubMed
    Score: 0.046
  4. Coded aperture nuclear scintigraphy: a novel small animal imaging technique. Mol Imaging. 2002 Oct; 1(4):344-53.
    View in: PubMed
    Score: 0.035
  5. Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT. AJNR Am J Neuroradiol. 2019 01; 40(1):142-149.
    View in: PubMed
    Score: 0.027
  6. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006 Dec; 140(6):932-40; discussion 940-1.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.